The dual approach, though rare, was linked to fewer 2-year MACE and lower long-term costs compared with angiography alone.

For example, in the CTO setting, “IVUS can facilitate proximal cap puncture, subintimal navigation, and reentry, whereas OCT ...

The coverage milestone follows the American Medical Association's implementation of new Category I CPT payment code 75577 for Heartflow Plaque Analysis effective January 1, 2026. Heartflow Plaque ...

Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in ...

ABSTRACT: Objective: To investigate the clinical value of optical coherence tomography (OCT) in determining stent deployment position and post-procedural optimization during percutaneous coronary ...

Background: Acute coronary obstruction (ACO) is a rare but potentially fatal complication of transcatheter aortic valve replacement (TAVR), particularly in patients with high-risk anatomy such as low ...

SOMERSET, N.J., Oct. 24, 2025 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

The OpusWave dual-sensor imaging system [Image courtesy of Terumo] Terumo Interventional Systems announced today that it received FDA 510(k) clearance for its OpusWave dual-sensor imaging system.